Anti-inflammatories

Inhaled Corticosteroids (21st June 2021)

Tocilizumab (24th May 2021)

Evidence reviews are in progress for a number of interventions, including:

  • Casirivimab-Indevimab
  • Baricitinib
  • Convalescent plasma

Please check back here for more Recommendations soon.